Ataxia and athetosis as side effects of chemotherapy with vincristine in non-Hodgkin's lymphoma
Carpentieri, U.; Lockhart, L.H.
Cancer Treatment Reports 62(4): 561-562
1978
ISSN/ISBN: 0361-5960 PMID: 657152 Document Number: 130998
Document emailed within 1 workday
Related Documents
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Durant, J.R.; Gams, R.A.; Bartolucci, A.A.; Dorfman, R.F. 1977: BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma Cancer Treatment Reports 61(6): 1085-1096
Fedder, G.; Somers, R. 1982: Non-Hodgkin lymphoma following radio- and chemotherapy of Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 126(38): 1730-1733
Diehl, L.F.; Perry, D.J.; Terebelo, H.; Baldwin, P.E.; Hurwitz, M.; Kimball, D.B.; Dorn, R.V. 1983: Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy Cancer Treatment Reports 67(9): 827-829
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Lambert, J.; Wijermans, P.W.; Dekker, G.A.; Ossenkoppele, G.J. 1991: Chemotherapy in non-Hodgkin's lymphoma during pregnancy Netherlands Journal of Medicine 38(1-2): 80-85
Horikoshi, N.; Inagaki, J.; Ogawa, M. 1983: Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(8): 1885-1891
Yazici, H.; Saip, P.; Inanç, S.; Onat, H.; Dalay, N. 1998: Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma Research Communications in Molecular Pathology and Pharmacology 100(3): 301-311
Jain, S.; Moger, V.; Kumari, S.; Varma, S. 2001: Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma Neurology India 49(4): 416
Fielding, A.K.; Pearce, R.M.; Goldstone, A.H. 1995: Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma New England Journal of Medicine 333(11): 729; Author Reply 730
Fujiu, K.; Sakuma, H.; Shio, Y.; Suzuki, H.; Mori, M. 2008: A case of non-Hodgkin's lymphoma after chemotherapy for cancer of unknown origin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(11): 1907-1909
Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Moore, D.T.; Taslimi, M.M. 1991: Multi-agent chemotherapy in a case of non-Hodgkin's lymphoma in second trimester of pregnancy Journal of the Tennessee Medical Association 84(9): 435-436
Picozzi, V.J.; Pohlman, B.L.; Morrison, V.A.; Lawless, G.D.; Lee, M.W.; Kerr, R.O.; Ford, J.M.; Delgado, D.J.; Fridman, M.; Carter, W.B. 2001: Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma Oncology 15(10): 1296-1306; Discussion: 1310-1311, 1314
Jurczak, W.; Nowak, W.; Wójcik, M.; Skotnicki, A. 1999: Non Hodgkin's lymphoma--treatment of choice and the role of high dose chemotherapy Przeglad lekarski 56 Suppl. 1: 80-89
Morikov, D.D.; Morikova, E.G.; Dvornichenko, V.V. 2015: Pharmacoeconomic Analysis of the use of Hepatoprotectors in Management of Drug-Associated Liver Injury Due to Hodgkin's Lymphoma Chemotherapy Antibiotiki i Khimioterapiia 60(7-8): 23-26
Landgren, O.; Algernon, C.; Axdorph, U.; Nilsson, B.; Wedelin, C.; Porwit-MacDonald, A.; Grimfors, G.; Björkholm, M. 2003: Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis Haematologica 88(4): 438-444
Abdou, A.G.; Kandil, M.; Eldien, M.S.; Abdallah, R. 2016: Splenic histiocyte-rich pseudotumor following chemotherapy for non Hodgkin diffuse large B cell lymphoma Pathologica 108(3): 140-143